These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17557273)

  • 21. Potential impact of Medicare Part D in the end-stage renal disease population.
    St Peter WL
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare Part D formulary coverage since program inception: are beneficiaries choosing wisely?
    Jackson EA; Axelsen KJ
    Am J Manag Care; 2008 Nov; 14(11 Suppl):SP29-35. PubMed ID: 18991478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare Part D--the sea of choices meets the donut hole.
    Flaer PJ; Dondériz A; Younis MZ
    J Health Care Finance; 2007; 34(1):1-7. PubMed ID: 18972980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Senior enrollment in Medicare Part D.
    Stefanacci R
    Manag Care; 2006 Jul; 15(7 Suppl 3):9-13. PubMed ID: 16898054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating new research into Medicare risk adjustment.
    Frogner BK; Anderson GF; Cohen RA; Abrams C
    Med Care; 2011 Mar; 49(3):295-300. PubMed ID: 21224739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do determinants of medicare supplemental coverage choice vary by income.
    Taylor EF; Chernew M; McLaughlin C
    J Health Soc Policy; 2006; 22(1):1-18. PubMed ID: 17135105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare program; policy and technical changes to the Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Apr; 73(73):20485-509. PubMed ID: 18464352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The continuing cost of privatization: extra payments to Medicare Advantage plans jump to $11.4 billion in 2009.
    Biles B; Pozen J; Guterman S
    Issue Brief (Commonw Fund); 2009 May; 51():1-18. PubMed ID: 19449498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using matched survey and administrative data to estimate eligibility for the Medicare Part D low-income subsidy program.
    Meijer E; Karoly LA; Michaud PC
    Soc Secur Bull; 2010; 70(2):63-82. PubMed ID: 20560303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does greater Medicare HMO enrollment cause adverse selection into Medigap?
    Desmond KA; Rice T; Fox PD
    Health Econ Policy Law; 2006 Jan; 1(Pt 1):3-21. PubMed ID: 18634700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare beneficiary knowledge of the Part D program and its relationship with voluntary enrollment.
    Howell BL; Wolff J; Herring B
    Medicare Medicaid Res Rev; 2012; 2(4):. PubMed ID: 24800154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: the price of contentment?
    Walberg MP; Patel RA
    J Am Pharm Assoc (2003); 2009; 49(6):777-82. PubMed ID: 19926558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient activation status as a predictor of patient experience among Medicare beneficiaries.
    Heller A; Elliott MN; Haviland AM; Klein DJ; Kanouse DE
    Med Care; 2009 Aug; 47(8):850-7. PubMed ID: 19584763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Older adults' drug benefit beliefs: construct definition and measure development.
    Cline RR; Gupta K; Singh RL
    Res Social Adm Pharm; 2008 Mar; 4(1):23-36. PubMed ID: 18342820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost of privatization: extra payments to Medicare Advantage plans--updated and revised.
    Biles B; Hersch Nicholas L; Cooper BS; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2006 Nov; 23():1-16. PubMed ID: 17153271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicare Part B income-related monthly adjustment amount. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2006 Oct; 71(208):62923-40. PubMed ID: 17076049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.